Business Context and Reporting Period
This Form 8-K is filed by XpresSpa Group, Inc. (trading symbol: XSPA) on April 22, 2020. The report details material amendments to a definitive agreement regarding a convertible note originally issued to Calm.com, Inc. in July 2019.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or margins. The primary financial instrument discussed is the "Calm Note," with the following characteristics:
- Principal Amount: $2,500,000
- Interest Rate: 5.00% unsecured
- Maturity Date: 2022
- Warrants: 937,500 shares of common stock
- Exercise Price: Reduced to $0.175 per share via anti-dilution provisions
Material Changes
The filing reports two significant amendments to the Calm Note on April 17, 2020, and April 22, 2020:
- Transfer of Ownership: The note was transferred from Calm.com, Inc. to B3D, LLC, an existing investor, in a private transaction.
- Conversion Mechanics: The note was amended to allow for direct conversion into Common Stock rather than Series E Convertible Preferred Stock.
- Beneficial Ownership Limitation: A restriction was added preventing conversion if it would cause the holder to beneficially own more than 4.99% of the outstanding common stock.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the amendments. The filing notes that aside from the transfer and conversion mechanism changes, the original terms, including the underlying conversion price and the number of shares issuable, remain in effect. No specific forward-looking guidance or new risk factors were disclosed in this report.
Investor Verification Checklist
- Verify the current beneficial ownership percentage of B3D, LLC to assess the impact of the 4.99% conversion limitation.
- Confirm the total number of shares outstanding to calculate the potential dilution from the $2.5 million note and associated warrants.
- Review the terms of the anti-dilution provision that reduced the warrant exercise price to $0.175.
- Check subsequent filings for any actual conversions of the note into common stock.